Thanks for sharing that info Mac :)
Printable View
Thanks for sharing that info Mac :)
Action a bit on the slow side today. Not too much volume so far
Reckon plenty of pent up demand here .... todays only Thursday so how about 90 by close of Friday
Well Houston Texas should be getting an earful about cxbladder very soon.
Notice that PEB did not exhibit last year at this event.
Also notice that Predictive did attend as well as mdx
Only forty five exhibitors
Maybe they will have a "field day":)
Houston we have lift off.
Nothing mate, 82/83 last 83 on light volume
I'm not sure if you were referring to me in that post as I was one of the few whom mentioned PEB's extremely high P/S ratio (37,000+ in october) however just for clarity I wasn't using this in isolation, rather I was comparable it to the historical P/S ratios for a similar company at a similar stage in their growth trajectory. My analysis showed that PEB's market cap (and therefore share-price) was extremely over-valued relative to a comparable company that was previously in a similar commercialisation phase.
I mentioned this several times in the thread, and not long after we saw a masssive retraction. Not boasting that I called it but the numbers at the time did show she was way off her fundamental value, at least as far as an early stage biotech/cancer diagnostic company goes.
I'm out sold all my holding for a very good profit very happy. Will keep my eye on it but wont buy in until after the AGM and if the numbers look much better than the last 6 months might get back in.
I will be interested in Mac's valuation plus the other ones coming out. Will use part of my profit to invest more in the ASX plenty of opportunities over there.
Cellmid CDY:ASX will be looking forward to a huge royalty of $5.40 or is it 54c. On that basis its probably fair to say its unlikely CDY will be paying a dividend this year.
Probably not enough left after tax.:)
http://pacificedge.co.nz/about-us/where-we-are/nz/
'In 2012, PEDNZ signed a non-exclusive agreement with Labtests to sell Cxbladder within the Auckland / Northland regions'
This concerns me.
Some time around mid last year I think it was, there was a full page ad for CxBladder in AIRNZ's KiaOra magazine. I thought that was a great idea. Yet seemingly the uptake has been very slow and some important people don't even know the product exists...
My point being, if they're struggling get traction after a few years in NZ, then how are they going to do it in the US? They may, but I fear it will be a long and expensive road.
As someone else said in their post, what incentive is there for US Urologists to use the product? Why should they change?
I don't think anybody is debating what an amazing product this is, that seems to be one thing everyone agrees on. But there's more to it than that. A great product will not necessarily sell itself or even get used. But concerningly $9mil won't sell it either yet. What are PEB doing to address this now?
Before I get red carded for downramping, please understand I'm still holding some PEB and I still support the company/product 100%. But I'm not in love with it and will not blindly leave my money in it. Questions need to be asked, investing is dynamic.
I'm sure a lot of questions are going to be asked and answered at the AGM. I hope they're planning on being there a while! I've seen some great questions to be asked on here. I think we should make a list of questions from sharetrader members to be presented* at the AGM with the answers to be posted here for everyones benefit.
I hope for the sake of patients, all investors and NZ in general PEB can crack this.
Happy investing,
NBT
*presented = correct terminology to keep Winner happy :)